Doctor profile · Federal record
Dr. Nibash Budhathoki, MBBS
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Hematology & Oncology Physician · Kansas City, MO
- NPI 1861876526
- Accepts Medicare
- 14 yrs in practice
- Licensed in 3 states
- Male
- Solo practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
4150 N Mulberry Dr Ste 150
Kansas City, MO 641161764
(913) 588-1227 - Additional location
-
230 Nebraska St
Sioux City, IA 511011733
(712) 252-0088 - Additional location
-
4000 Cambridge St
Kansas City, KS 661608501
Credentials & registration
- NPI registered
- July 2015 — 11 yrs on file
- Profile last updated
- March 3, 2026
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (3)
- Missouri #2026003890 · Kansas #04-52391 · Iowa #MD-48110
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1861876526. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
117,369
Distinct HCPCS
10
Medicare allowed
$2,772,990
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 20,800 | 37 | $54 | |
J9299 |
Injection, nivolumab, 1 mg | 18,700 | 18 | $28 | |
J1453 |
Injection, fosaprepitant, 1 mg | 16,800 | 52 | $0 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 10,980 | 12 | $48 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 8,560 | 12 | $0 | |
J1756 |
Injection, iron sucrose, 1 mg | 7,600 | 12 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 6,590 | 16 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 6,420 | 34 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,914 | 89 | $0 | |
Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 1,800 | 12 | $28 |
In context: peer comparison
Among 13 peers in Kansas City Hematology & Oncology Physician, average services per provider: 805. This provider delivers 146× the peer median.Open Payments
Industry payments received
All-time total
$1,171
Transactions
49
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $183.61 | |
| Novartis Pharmaceuticals Corporation | 8 | $160.01 | |
| AstraZeneca Pharmaceuticals Lp | 5 | $91.06 | |
| Daiichi Sankyo INC. | 3 | $73.27 | |
| Genentech USA, INC. | 3 | $63.10 | |
| Pfizer INC. | 3 | $57.70 | |
| Celgene Corporation | 3 | $50.54 | |
| Merck Sharp & Dohme LLC | 2 | $36.72 | |
| TerSera Therapeutics LLC | 1 | $35.48 | |
| Gilead Sciences, INC. | 2 | $31.93 | |
| Eisai INC. | 2 | $30.08 | |
| Genzyme Corporation | 1 | $28.27 | |
| Sobi, INC | 2 | $28.17 | |
| PharmaEssentia USA Corporation | 1 | $23.33 | |
| Abbvie INC. | 1 | $21.76 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
848
Patients
205
Total drug cost
$2,562,861
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 138 | 43 | $3,408 |
| Dexamethasone | Generic | 102 | 35 | $1,285 |
| Letrozole | Generic | 78 | 14 | $4,625 |
| Hydroxyurea | Generic | 60 | 15 | $1,788 |
| Ondansetron Hcl | Generic | 56 | 25 | $582 |
| Tamoxifen Citrate | Generic | 53 | 12 | $1,115 |
| Revlimid (Lenalidomide) | Brand | 52 | 0 | $952,313 |
| Acyclovir | Generic | 49 | 0 | $673 |
| Calquence (Acalabrutinib Maleate) | Brand | 48 | 0 | $595,020 |
| Gabapentin | Generic | 41 | 11 | $365 |
Frequently asked questions
What is Dr. Nibash Budhathoki's medical specialty?
Dr. Nibash Budhathoki practices Hematology & Oncology Physician in Kansas City, MO.
Where does Dr. Nibash Budhathoki practice?
Dr. Nibash Budhathoki practices at 4150 N Mulberry Dr Ste 150, Kansas City, MO 641161764. Office phone: 9135881227.
What is Dr. Nibash Budhathoki's NPI?
Dr. Nibash Budhathoki's National Provider Identifier (NPI) is 1861876526, issued by NPPES.
Does Dr. Nibash Budhathoki accept Medicare assignment?
Yes. Dr. Nibash Budhathoki accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Nibash Budhathoki commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, nivolumab, 1 mg (HCPCS J9299); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.